A Novel Ivermectin-Derived Compound D4 and Its Antimicrobial/Biofilm Properties against MRSA
Open Access
- 20 February 2021
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 10 (2) , 208
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) and its biofilms infection is still a serious threat to global health. It is urgent to develop efficient drugs by repositioning or designing drugs to solve this problem. In this study, the antibacterial/biofilm activity and mechanisms of ivermectin (D) and its 4″-position amino substitution derivative (D4) against MRSA were investigated. The minimum inhibitory concentration (MIC) of D was 20 μg/mL, which is four times higher than D4 (MIC = 5 μg/mL). The mechanism research demonstrated that D4 was more potent than D at destroying bacterial cell wall, permeating cell membrane (6.25–36.0% vs 1.92–6.04%) and binding to MRSA genomic DNA. Moreover, after incubation with 10–40 μg/mL D4 for 24 h, the percentages of biofilm decreased by 21.2–92.9%, which was more effective than D (no significant change at 40 μg/mL). The antibiofilm effect is achieved by regulating the expression of related genes (RSH, relQ, rsbU, sigB, spA, and icaD). Additionally, though the higher hemolysis makes D4 a safety risk for intravenous injection, other administration options could be considered as well. Therefore, all the results have indicated that D4 may be a potential candidate compound for the treatment of MRSA and its biofilm infections.Keywords
Funding Information
- National Natural Science Foundation of China (82002190)
- Natural Science Foundation of Ningbo Municipality (2019A610196)
- Research Fund of Ningbo University (421807120, 421906052, 422003802)
This publication has 42 references indexed in Scilit:
- Effects of Aggregate and Individual Antibiotic Exposure on Vancomycin MICs for Staphylococcus aureus Isolates Recovered from Pediatric PatientsJournal of Clinical Microbiology, 2013
- Purification and Characterization of Biofilm-Associated EPS Exopolysaccharides from ESKAPE Organisms and Other PathogensPLOS ONE, 2013
- Anti-biofilm activities of quercetin and tannic acid againstStaphylococcus aureusBiofouling, 2013
- How Staphylococcus aureus biofilms develop their characteristic structureProceedings of the National Academy of Sciences, 2012
- Synthesis and antifungal properties of 6-amino-6-deoxyinulin, a kind of precursors for facile chemical modifications of inulinCarbohydrate Polymers, 2012
- Staphylococcus aureusbiofilmsVirulence, 2011
- Interconnections between Sigma B, agr , and Proteolytic Activity in Staphylococcus aureus Biofilm MaturationInfection and Immunity, 2009
- Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substancesNature Protocols, 2008
- Ivermectin distribution in the plasma and tissues of patients infected with Onchocerca volvulusEuropean Journal of Clinical Pharmacology, 1996
- 4″-Deoxy-4″-aminoavermectins with potent broad spectrum antiparasitic activitiesBioorganic & Medicinal Chemistry Letters, 1995